Research·APAC
PsiQuantum Collaborates with National Cancer Center Japan
Key Points
- 1Collaborative research agreement announced for drug discovery
- 2Focus on utility-scale quantum computing applications
- 3Enhances Japan's healthcare research capacity with advanced tech
- 4Collaborative research agreement announced for drug discovery • Focus on utility-scale quantum computing applications • Enhances Japan's healthcare research capacity with advanced tech
PsiQuantum has entered into a collaborative research agreement with the National Cancer Center Japan, aiming to leverage utility-scale quantum computing for innovating drug discovery in oncology and healthcare. This partnership highlights the potential application of quantum technology to solve complex computational challenges in medical research.
Free Daily Briefing
Top AI intelligence stories delivered each morning.
Related Articles
ARC Prize Analysis Reveals AI Models' Systematic Errors
Research2 May
CERN Discovers Anomaly in Particle Decay at LHC
Research2 May
KPR Institute Develops Hybrid Model for Health Monitoring
Research2 May
Arabic AI Models Misidentify Cultural Items, Risking Credibility
Research1 May
Top U.S. Scientist Moves to Singapore Amid Policy Changes
Research1 May